Therapeutic Asset Ratings
315 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
E-7820
Acute Myeloid Leukemia
Memorial Sloan Kettering Cancer Center
P2
CC
(45)
Anti-Cll1 Cart Cells
Acute Myeloid Leukemia
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
P1/2
CC
(45)
Ato
Acute Myeloid Leukemia
Ascentage Pharma Group Inc.
P1/2
CC
(45)
bg1805
Acute Myeloid Leukemia
Guangzhou Bio-gene Technology Co., Ltd
P1/2
CC
(45)
cd123-car-nk cells
Acute Myeloid Leukemia
Chongqing Precision Biotech Co., Ltd
P1/2
CC
(45)
CD123-CAR T
Acute Myeloid Leukemia
Shenzhen Geno-Immune Medical Institute
P1/2
CC
(45)
cd123-cd33 ccar t cells
Acute Myeloid Leukemia
Essen Biotech
P1/2
CC
(45)
cd7-specific car gene-engineered t cells
Acute Myeloid Leukemia
Shenzhen Geno-Immune Medical Institute
P1/2
CC
(45)
Dubermatinib
Acute Myeloid Leukemia
Uma Borate
P1/2
CC
(45)
Orca-Q
Acute Myeloid Leukemia
University of Florida
P1/2
CC
(45)
rc1012
Acute Myeloid Leukemia
Guangdong Ruishun Biotech Co., Ltd
P1/2
CC
(45)
Sndx-5613
Acute Myeloid Leukemia
Syndax Pharmaceuticals
P1/2
CC
(45)
Γδ T Cells
Acute Myeloid Leukemia
Chinese PLA General Hospital
P1/2
CC
(45)
Lapine T-Lymphocyte Immune Globulin
Acute Myeloid Leukemia
Children's Oncology Group
P3
CC
(43)
Tamibarotene
Acute Myeloid Leukemia
Syros Pharmaceuticals
P2
CC
(43)
ctx131
Acute Myeloid Leukemia
CRISPR Therapeutics
P1/2
CC
(42)
cd70-targeting car-t cells
Acute Myeloid Leukemia
Baylor College of Medicine
P1
CC
(41)
Camidanlumab Tesirine
Acute Myeloid Leukemia
Gwynn Long, M.D.
P2
CC
(40)
Anti-Flt3 Car-T
Acute Myeloid Leukemia
The First Affiliated Hospital of Soochow University
P1/2
CC
(40)
Astx029-01
Acute Myeloid Leukemia
M.D. Anderson Cancer Center
P1/2
CC
(40)
Bexmarilimab
Acute Myeloid Leukemia
Faron Pharmaceuticals Ltd
P1/2
CC
(40)
cll1/+cd33 car-t
Acute Myeloid Leukemia
Shenzhen Geno-Immune Medical Institute
P1/2
CC
(40)
Ctx-712
Acute Myeloid Leukemia
Chordia Therapeutics, Inc.
P1/2
CC
(40)
Cytokine-Treated Veto Cells
Acute Myeloid Leukemia
M.D. Anderson Cancer Center
P1/2
CC
(40)
Debio 1562M
Acute Myeloid Leukemia
Debiopharm International SA
P1/2
CC
(40)
Showing 151 to 175 of 315 assets
Previous
Page 7 of 13
Next
